Retour

SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study

News Clinical Study

– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3 REGAL Trial Patients Treatment and Follow-Up Without Any Modifications –

GlobeNewswire Inc. • 29/04/2024 à 14:45:00
SELLAS Life Sciences Group, Inc. Common Stock
Address: 7 TIMES SQUARE
Postal Code: 10036
City: NEW YORK
State: NY
Phone Number: (646) 200-5278
Website: https://www.sellaslifesciences.com
Status: Active
Company Info

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

List Date2008-03-12
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001390478
Composite figiBBG000VC77H7
Share Class figiBBG001T223C9
Market Cap78,257,927 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees17
Share Class Shares Outstanding57760000
Weighted Shares Outstanding57754928
Round Lot100
Updated date2024-05-12
Stats
Last 5 days
15-05
14-05
13-05
10-05
9-05
Last
1.465
1.36
1.375
1.346
1.305
Variance
7.09%
-0.95%
2.15%
3.7%
-1.36%
Open
1.368
1.373
1.346
1.298
1.323
Highest
1.474
1.385
1.405
1.415
1.325
Lowest
1.47
1.385
1.4
1.415
1.325
History
PeriodVarhighestlowest
1 week
10.73%
1.325
1.325
1 month
9.74%
1.468
1.275
3 month
115.12%
0.849
0.846
6 month
115.12%
0.849
0.846
1 year
115.12%
0.849
0.846
3 year
115.12%
0.849
0.846
5 year
115.12%
0.849
0.846
10 year
115.12%
0.849
0.846
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Assets 29,104,000 18,566,000 8,086,000 UNPUB
Current Assets 26,022,000 15,581,000 5,203,000 UNPUB
Current Liabilities 15,511,000 13,421,000 11,735,000 UNPUB
Equity 13,169,000 4,843,000 -3,827,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 13,169,000 4,843,000 -3,827,000 UNPUB
Liabilities 15,935,000 13,723,000 11,913,000 UNPUB
Liabilities And Equity 29,104,000 18,566,000 8,086,000 UNPUB
Noncurrent Assets 3,082,000 2,985,000 2,883,000 UNPUB
Noncurrent Liabilities 424,000 302,000 178,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 -3,318,000 -9,838,000 UNPUB
Net Cash Flow, Continuing 0 -3,318,000 -9,838,000 UNPUB
Net Cash Flow From Financing Activities 18,904,000 -29,000 54,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 18,904,000 -29,000 54,000 UNPUB
Net Cash Flow From Investing Activities -6,777,000 4,277,000 -3,000,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -6,777,000 4,277,000 -3,000,000 UNPUB
Net Cash Flow From Operating Activities -12,127,000 -7,566,000 -6,892,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -12,127,000 -7,566,000 -6,892,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Comprehensive Income/Loss -11,097,000 -8,840,000 -9,267,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -11,097,000 -8,840,000 -9,267,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-09 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue 0 0 0 UNPUB
Costs And Expenses 11,281,000 9,050,000 9,361,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -11,097,000 -8,840,000 -9,267,000 UNPUB
Income/Loss From Continuing Operations Before Tax -11,281,000 -9,050,000 -9,361,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -11,097,000 -8,840,000 -9,267,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -11,097,000 -8,840,000 -9,267,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -11,097,000 -8,840,000 -9,267,000 UNPUB
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -11,281,000 -9,050,000 -9,361,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 0 0 0 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-16
Assets 21,434,000 32,210,000 26,001,000 20,943,000
Current Assets 17,839,000 28,737,000 22,605,000 17,756,000
Current Liabilities 10,679,000 12,186,000 12,553,000 15,515,000
Equity 4,025,000 19,057,000 12,597,000 4,851,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 4,025,000 19,057,000 12,597,000 4,851,000
Liabilities 17,409,000 13,153,000 13,404,000 16,092,000
Liabilities And Equity 21,434,000 32,210,000 26,001,000 20,943,000
Noncurrent Assets 3,595,000 3,473,000 3,396,000 3,187,000
Noncurrent Liabilities 0 0 851,000 577,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 5,632,000 -5,639,000 -4,230,000
Net Cash Flow, Continuing 0 5,632,000 -5,639,000 -4,230,000
Net Cash Flow From Financing Activities 47,000 22,996,000 107,000 24,079,000
Net Cash Flow From Financing Activities, Continuing 47,000 22,996,000 107,000 24,079,000
Net Cash Flow From Investing Activities 7,103,000 -11,603,000 0 -4,500,000
Net Cash Flow From Investing Activities, Continuing 7,103,000 -11,603,000 0 -4,500,000
Net Cash Flow From Operating Activities -7,150,000 -5,761,000 -5,746,000 -23,809,000
Net Cash Flow From Operating Activities, Continuing -7,150,000 -5,761,000 -5,746,000 -23,809,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-16
Comprehensive Income/Loss -16,744,000 -8,414,000 -7,022,000 -41,301,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -16,744,000 -8,414,000 -7,022,000 -41,301,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-16
Basic Earnings Per Share -1 0 0 -2
Benefits Costs and Expenses 17,735,000 8,623,000 7,146,000 42,301,000
Cost Of Revenue 100,000 0 0 100,000
Costs And Expenses 17,735,000 8,623,000 7,146,000 42,950,000
Diluted Earnings Per Share -1 0 0 -2
Gross Profit 900,000 0 0 900,000
Income/Loss From Continuing Operations After Tax -16,744,000 -8,414,000 -7,022,000 -41,301,000
Income/Loss From Continuing Operations Before Tax -16,735,000 -8,623,000 -7,146,000 -41,301,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -16,744,000 -8,414,000 -7,022,000 -41,301,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -16,744,000 -8,414,000 -7,022,000 -41,301,000
Net Income/Loss Available To Common Stockholders, Basic -16,744,000 -8,414,000 -7,022,000 -41,301,000
Operating Expenses 17,635,000 8,623,000 7,146,000 42,850,000
Operating Income/Loss -16,735,000 -8,623,000 -7,146,000 -41,950,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 1,000,000 0 0 1,000,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-03-31
Assets 40,575,000 43,624,000 37,952,000 26,275,000
Current Assets 31,431,000 34,575,000 28,974,000 23,044,000
Current Liabilities 5,971,000 4,239,000 5,319,000 4,982,000
Equity 28,742,000 33,415,000 26,607,000 20,347,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 28,742,000 33,415,000 26,607,000 20,347,000
Liabilities 11,833,000 10,209,000 11,345,000 5,928,000
Liabilities And Equity 40,575,000 43,624,000 37,952,000 26,275,000
Noncurrent Assets 9,144,000 9,049,000 8,978,000 3,231,000
Noncurrent Liabilities 0 0 6,026,000 946,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 0
Net Cash Flow, Continuing 0 0 0 0
Net Cash Flow From Financing Activities 3,000,000 6,782,000 2,242,000 12,074,000
Net Cash Flow From Financing Activities, Continuing 3,000,000 6,782,000 2,242,000 12,074,000
Net Cash Flow From Investing Activities 7,269,000 -1,884,000 3,636,000 13,947,000
Net Cash Flow From Investing Activities, Continuing 7,269,000 -1,884,000 3,636,000 13,947,000
Net Cash Flow From Operating Activities -10,269,000 -4,898,000 -5,878,000 -26,021,000
Net Cash Flow From Operating Activities, Continuing -10,269,000 -4,898,000 -5,878,000 -26,021,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-03-31
Comprehensive Income/Loss -2,403,000 -4,613,000 -7,085,000 -20,699,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,403,000 -4,613,000 -7,085,000 -20,699,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-03-31
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses 7,945,000 6,353,000 6,977,000 28,536,000
Cost Of Revenue 100,000 100,000 0 200,000
Costs And Expenses 7,945,000 6,353,000 6,977,000 32,894,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit 5,600,000 1,800,000 0 7,400,000
Income/Loss From Continuing Operations After Tax -2,403,000 -4,613,000 -7,085,000 -20,699,000
Income/Loss From Continuing Operations Before Tax -2,245,000 -4,453,000 -6,977,000 -20,936,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB -237,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,403,000 -4,613,000 -7,085,000 -20,699,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,403,000 -4,613,000 -7,085,000 -20,699,000
Net Income/Loss Available To Common Stockholders, Basic -2,403,000 -4,613,000 -7,085,000 -20,699,000
Operating Expenses 7,845,000 6,253,000 6,977,000 32,694,000
Operating Income/Loss -2,245,000 -4,453,000 -6,977,000 -25,294,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 5,700,000 1,900,000 0 7,600,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-13 2021-03-23
Assets 17,026,000 14,514,000 18,509,000 46,049,000
Current Assets 8,790,000 5,229,000 9,333,000 36,925,000
Current Liabilities 3,635,000 4,325,000 4,219,000 12,336,000
Equity 8,062,000 3,783,000 7,948,000 27,961,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 8,062,000 3,783,000 7,948,000 27,961,000
Liabilities 8,964,000 10,731,000 10,561,000 18,088,000
Liabilities And Equity 17,026,000 14,514,000 18,509,000 46,049,000
Noncurrent Assets 8,236,000 9,285,000 9,176,000 9,124,000
Noncurrent Liabilities 0 0 6,342,000 5,752,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-13 2021-03-23
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 0
Net Cash Flow, Continuing 0 0 0 0
Net Cash Flow From Financing Activities 6,300,000 -25,000 8,492,000 38,442,000
Net Cash Flow From Financing Activities, Continuing 6,300,000 -25,000 8,492,000 38,442,000
Net Cash Flow From Investing Activities 531,000 3,406,000 -4,863,000 -28,025,000
Net Cash Flow From Investing Activities, Continuing 531,000 3,406,000 -4,863,000 -28,025,000
Net Cash Flow From Operating Activities -6,831,000 -3,381,000 -3,629,000 -10,417,000
Net Cash Flow From Operating Activities, Continuing -6,831,000 -3,381,000 -3,629,000 -10,417,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-13 2021-03-23
Comprehensive Income/Loss -4,143,000 -4,425,000 -4,473,000 -16,757,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,143,000 -4,425,000 -4,473,000 -16,757,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-13 2021-03-23
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 4,167,000 4,267,000 4,473,000 18,674,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 4,064,000 4,267,000 4,492,000 18,882,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,143,000 -4,425,000 -4,473,000 -16,757,000
Income/Loss From Continuing Operations Before Tax -4,143,000 -4,266,000 -4,492,000 -16,774,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB -17,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,143,000 -4,425,000 -4,473,000 -16,757,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,143,000 -4,425,000 -4,473,000 -16,757,000
Net Income/Loss Available To Common Stockholders, Basic -4,221,000 -4,425,000 -4,473,000 -16,835,000
Operating Expenses 4,064,000 4,267,000 4,492,000 18,882,000
Operating Income/Loss -4,040,000 -4,266,000 -4,492,000 -16,982,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 78,000 0 0 78,000
Preferred Stock Dividends And Other Adjustments 78,000 0 0 78,000
Revenues 24,000 1,000 0 1,900,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-15 2019-08-14 2019-11-14 2020-03-13
Assets 14,927,000 25,034,000 21,484,000 16,609,000
Current Assets 3,416,000 13,641,000 10,211,000 8,242,000
Current Liabilities 5,804,000 5,400,000 5,574,000 5,290,000
Equity 2,950,000 14,338,000 10,637,000 6,093,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 2,950,000 14,338,000 10,637,000 6,093,000
Liabilities 11,977,000 10,696,000 10,847,000 10,516,000
Liabilities And Equity 14,927,000 25,034,000 21,484,000 16,609,000
Noncurrent Assets 11,511,000 11,393,000 11,273,000 8,367,000
Noncurrent Liabilities 0 0 5,273,000 5,226,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-15 2019-08-14 2019-11-14 2020-03-13
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 0
Net Cash Flow, Continuing 0 0 0 0
Net Cash Flow From Financing Activities 2,230,000 14,831,000 189,000 19,569,000
Net Cash Flow From Financing Activities, Continuing 2,230,000 14,831,000 189,000 19,569,000
Net Cash Flow From Investing Activities 2,761,000 -10,175,000 3,631,000 -1,926,000
Net Cash Flow From Investing Activities, Continuing 2,761,000 -10,175,000 3,631,000 -1,926,000
Net Cash Flow From Operating Activities -4,991,000 -4,656,000 -3,820,000 -17,643,000
Net Cash Flow From Operating Activities, Continuing -4,991,000 -4,656,000 -3,820,000 -17,643,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-15 2019-08-14 2019-11-14 2020-03-13
Comprehensive Income/Loss -4,537,000 -3,134,000 -4,202,000 -19,292,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,537,000 -3,134,000 -4,202,000 -19,292,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-15 2019-08-14 2019-11-14 2020-03-13
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 4,551,000 4,019,000 4,184,000 19,490,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 4,359,000 4,019,000 4,184,000 20,041,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,537,000 -3,134,000 -4,202,000 -19,292,000
Income/Loss From Continuing Operations Before Tax -4,537,000 -4,001,000 -4,125,000 -19,372,000
Income Tax Expense/Benefit 0 0 0 -81,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,537,000 -3,134,000 -4,202,000 -19,292,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,537,000 -3,134,000 -4,202,000 -19,292,000
Net Income/Loss Available To Common Stockholders, Basic -4,976,000 -4,086,000 -11,470,000 -27,951,000
Operating Expenses 4,359,000 4,019,000 4,184,000 20,041,000
Operating Income/Loss -4,345,000 -4,001,000 -4,125,000 -19,923,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 439,000 952,000 7,268,000 8,659,000
Preferred Stock Dividends And Other Adjustments 439,000 952,000 7,268,000 8,659,000
Revenues 14,000 18,000 59,000 118,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 2018-11-14 2019-03-22
Assets 33,485,000 31,973,000 38,470,000 16,915,000
Current Assets 13,072,000 10,926,000 17,807,000 5,838,000
Current Liabilities 25,747,000 24,852,000 11,997,000 5,974,000
Equity -1,318,000 -2,483,000 18,457,000 5,245,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent -1,318,000 -2,483,000 18,457,000 5,245,000
Liabilities 34,803,000 34,456,000 20,013,000 11,670,000
Liabilities And Equity 33,485,000 31,973,000 38,470,000 16,915,000
Noncurrent Assets 20,413,000 21,047,000 20,663,000 11,077,000
Noncurrent Liabilities 9,056,000 9,604,000 8,016,000 5,696,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 2018-11-14 2019-03-22
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 0
Net Cash Flow, Continuing 0 0 0 0
Net Cash Flow From Financing Activities 4,739,000 4,208,000 14,252,000 23,123,000
Net Cash Flow From Financing Activities, Continuing 4,739,000 4,208,000 14,252,000 23,123,000
Net Cash Flow From Investing Activities 664,000 2,091,000 -87,000 7,299,000
Net Cash Flow From Investing Activities, Continuing 664,000 2,091,000 -87,000 7,299,000
Net Cash Flow From Operating Activities -5,403,000 -6,299,000 -14,165,000 -30,422,000
Net Cash Flow From Operating Activities, Continuing -5,403,000 -6,299,000 -14,165,000 -30,422,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 2018-11-14 2019-03-22
Comprehensive Income/Loss -7,995,000 -6,062,000 -290,000 -27,670,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,995,000 -6,062,000 -290,000 -27,670,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 2018-11-14 2019-03-22
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 7,899,000 6,501,000 3,061,000 28,782,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 5,684,000 6,501,000 3,061,000 31,089,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -7,995,000 -6,062,000 -290,000 -27,670,000
Income/Loss From Continuing Operations Before Tax -7,995,000 -6,623,000 -3,135,000 -29,048,000
Income Tax Expense/Benefit 0 163,000 0 -1,400,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -7,995,000 -6,062,000 -290,000 -27,670,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -7,995,000 -6,062,000 -290,000 -27,670,000
Net Income/Loss Available To Common Stockholders, Basic -9,963,000 -8,530,000 -9,435,000 -41,251,000
Operating Expenses 5,684,000 6,501,000 3,061,000 31,089,000
Operating Income/Loss -5,780,000 -6,623,000 -3,135,000 -31,355,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 1,968,000 2,468,000 9,145,000 13,581,000
Preferred Stock Dividends And Other Adjustments 1,968,000 2,468,000 9,145,000 13,581,000
Revenues -96,000 -122,000 -74,000 -266,000
Calendar
16 May 2024 (Time UTC) Actual Previous Consensus
★
16:30
United States
3331000000000.000
★★
16:30
United States
7353000000000.000
★
15:50
United States
★★
11:30
United States
★
11:30
United States
5.275
★
11:30
United States
5.270
★
11:30
United States
★
11:30
United States
★★
10:30
United States
★
10:30
United States
MAY 10
70000000000.000
79000000000.000
76000000000.000
★
10:30
United States
MAY 10
★★
10:00
United States
★
09:15
United States
APR
-0.300
0.200
0.100
★★
09:15
United States
APR
-0.380
0.090
★
09:15
United States
APR
78.400
78.500
78.400
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:SLS240419P00004000 OPASPS Put American 100 4 BATO 2024-04-19
O:SLS240419P00001000 OPASPS Put American 100 1 BATO 2024-04-19
O:SLS240419C00004000 OCASPS Call American 100 4 BATO 2024-04-19
O:SLS240419C00001000 OCASPS Call American 100 1 BATO 2024-04-19
O:SLS240419P00006000 OPASPS Put American 100 6 BATO 2024-04-19
O:SLS240419P00002000 OPASPS Put American 100 2 BATO 2024-04-19
O:SLS240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:SLS240419P00001500 OPASPS Put American 100 1.5 BATO 2024-04-19
O:SLS240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:SLS240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:SLS240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:SLS240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:SLS240419P00000500 OPASPS Put American 100 0.5 BATO 2024-04-19
O:SLS240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:SLS240419C00006000 OCASPS Call American 100 6 BATO 2024-04-19
O:SLS240419C00002000 OCASPS Call American 100 2 BATO 2024-04-19
O:SLS240419C00001500 OCASPS Call American 100 1.5 BATO 2024-04-19
O:SLS240419C00000500 OCASPS Call American 100 0.5 BATO 2024-04-19
O:SLS240315P00004000 OPASPS Put American 100 4 BATO 2024-03-15
O:SLS240315P00003000 OPASPS Put American 100 3 BATO 2024-03-15
O:SLS240315P00002000 OPASPS Put American 100 2 BATO 2024-03-15
O:SLS240315P00001000 OPASPS Put American 100 1 BATO 2024-03-15
O:SLS240315C00004000 OCASPS Call American 100 4 BATO 2024-03-15
O:SLS240315C00003000 OCASPS Call American 100 3 BATO 2024-03-15
O:SLS240315C00002000 OCASPS Call American 100 2 BATO 2024-03-15
O:SLS240315C00001000 OCASPS Call American 100 1 BATO 2024-03-15
O:SLS240315P00001500 OPASPS Put American 100 1.5 BATO 2024-03-15
O:SLS240315P00000500 OPASPS Put American 100 0.5 BATO 2024-03-15
O:SLS240315C00001500 OCASPS Call American 100 1.5 BATO 2024-03-15
O:SLS240315C00000500 OCASPS Call American 100 0.5 BATO 2024-03-15
O:SLS240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:SLS240216P00004000 OPASPS Put American 100 4 BATO 2024-02-16
O:SLS240216P00003000 OPASPS Put American 100 3 BATO 2024-02-16
O:SLS240216P00002000 OPASPS Put American 100 2 BATO 2024-02-16
O:SLS240216P00001000 OPASPS Put American 100 1 BATO 2024-02-16
O:SLS240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:SLS240216C00004000 OCASPS Call American 100 4 BATO 2024-02-16
O:SLS240216C00003000 OCASPS Call American 100 3 BATO 2024-02-16
O:SLS240216C00002000 OCASPS Call American 100 2 BATO 2024-02-16
O:SLS240216C00001000 OCASPS Call American 100 1 BATO 2024-02-16
O:SLS240119P00006000 OPASPS Put American 100 6 BATO 2024-01-19
O:SLS240119C00006000 OCASPS Call American 100 6 BATO 2024-01-19
O:SLS240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:SLS240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:SLS240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:SLS240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:SLS240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:SLS240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:SLS240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:SLS240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:SLS240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:SLS240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:SLS240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:SLS240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:SLS240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:SLS240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:SLS240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:SLS240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:SLS240119P00004000 OPASPS Put American 100 4 BATO 2024-01-19
O:SLS240119P00001000 OPASPS Put American 100 1 BATO 2024-01-19
O:SLS240119C00004000 OCASPS Call American 100 4 BATO 2024-01-19
O:SLS240119C00001000 OCASPS Call American 100 1 BATO 2024-01-19
O:SLS231215P00004000 OPASPS Put American 100 4 BATO 2023-12-15
O:SLS231215P00001000 OPASPS Put American 100 1 BATO 2023-12-15
O:SLS231215C00004000 OCASPS Call American 100 4 BATO 2023-12-15
O:SLS231215C00001000 OCASPS Call American 100 1 BATO 2023-12-15
O:SLS231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:SLS231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:SLS231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:SLS231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:SLS231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:SLS231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:SLS231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:SLS231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:SLS231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:SLS231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:SLS231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:SLS231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:SLS231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:SLS231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:SLS231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:SLS231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:SLS231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:SLS231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:SLS230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:SLS230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:SLS230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:SLS230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:SLS230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:SLS230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:SLS230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:SLS230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:SLS230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:SLS230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:SLS230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:SLS230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Stocks Earnings Releases and Operating Results
SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update
- Announced Independent Data Monitoring Committee’s (IDMC) Recommendation to Continue the Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Without Modifications: IDMC to Reconvene in June -
GlobeNewswire Inc. • 1d ago
Health Health
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential –
GlobeNewswire Inc. • 2w ago
News Clinical Study
SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study
– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3 REGAL Trial Patients Treatment and Follow-Up Without Any Modifications –
GlobeNewswire Inc. • 2w ago
News Advisory
Solaris Signs Updated Impact and Benefits Agreement for Warintza Project
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) and the Shuar communities of Warints and Yawi are pleased to announce the signing of an updated Impact and Benefits Agreement (“IBA”) for the Warintza Project (“Warintza” or “the Project”) in southeastern Ecuador to reflect the continued growth and advancement of the Project. The updated IBA reaffirms certainty of community support for the responsible development of the Project.
GlobeNewswire Inc. • 4w ago
Stocks Technical Analysis
Solaris Resources to Commence Trading on NYSE American Under SLSR
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce that it has received approval to list its common shares on the NYSE American LLC (“NYSE American”) with trading expected to commence on Friday, April 19, 2024 under the symbol “SLSR”. The Company will remain listed on the Toronto Stock Exchange under the symbol “SLS”.
GlobeNewswire Inc. • 1mo ago
Stocks Earnings Releases and Operating Results
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) --  SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today reported financial results for the full year ended December 31, 2023, and provided a corporate update.
GlobeNewswire Inc. • 1mo ago
stocks Calendar of Events
SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and Provides Steering Committee Update on Phase 3 REGAL Study
- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April -
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and Provides Steering Committee Update on Phase 3 REGAL Study
- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April -
GlobeNewswire Inc. • 1mo ago
Stocks Financing Agreements
SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced the closing of its previously announced registered direct offering of 13,029,316 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 13,029,316 shares of common stock issued in a concurrent private placement (together with the registered direct offering, the "Offering") at a combined purchase price of $1.535 per share and accompanying warrant, priced at-the-market under Nasdaq rules. The warrants have an exercise price of $1.41 per share, are immediately exercisable upon issuance and will expire 5.5 years from issuance.
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET
-  Update on the Phase 3 REGAL Clinical Trial of GPS in Acute Myeloid Leukemia (AML) -
GlobeNewswire Inc. • 1mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT